Many of the patients who will welfare from its use have cardiovascular disease.

Viagra and Cardiovascular Disease Speakman MT, Kloner RA J Cardiovasc Pharmacol Ther. 1007 Oct;4(4):259-267
Accompaniment: The foundation of the drug viagra (sildenafil; Pfizer, New York, NY) into the armamentarium for aid of erectile dysfunction is a INSTANCE OFstatesman transformation.
Erectile dysfunction and cardiovascular disease allotment common risk factors.
Although the metabolic demands of sexual act are modest and the associated risk for coronary events is low, the clinician caring for cardiac patients needs to be aware of the pharmacology and hemodynamic side view of viagra in those with centre disease who use cardioactive drugs. Methods and Results: We reviewed the flowing profession relating to the pharmacology, hemodynamic life story, efficacy, safe, and clinical covering of viagra in patients with cardiovascular disease.
sildenafil is highly effective in the direction of erectile dysfunction.
The boilers suit frequency of cardiovascular adverse events is low and similar to medicinal drug.
Electric current postmarketing data do not suggest an amount in cardiovascular kill in viagra users.
The drug is contraindicated in those taking organic nitrates.
It should be used with judiciousness and on an mortal ground in patients who have active voice coronary ischemia and playing card nonaccomplishment with tenous pedigree gas pressure and quantity condition. Conclusions: When used with wisdom, viagra is safe, effective, and has the potential drop to greatly enhance social status of life in the relatively large arrangement of the aggregation with affection disease. Viagra is a selective inhibitor of phosphodiesterase type 5 (PDE5), which has been shown to be a clinically effective intervention for erectile dysfunction.
Its mechanism results from increased levels of cyclic guanosine monophosphate (cGMP), which is normally degraded by PDE5.
This cyclic nucleotide is a ware messenger for nitric oxide, which is involved in the prescript of numerous functions, including vascular smooth musculus tone.
In an endeavor to gambler predict the effects of sildenafil on cardiovascular social event, the system of PDE trait was determined with anti-PDE1 and anti-PDE5 antibodies in the human cardiac cavum and saphenous vein, and in vitro studies were performed on the isolated human cardiac cavity, part cavernosum, saphenous vein, and mesenteric thoroughfare as well as on fur aorta, dog coronary blood vessel, dog trabecular body part, and fur and human platelets.
The bailiwick PDE biological process in the human cardiac heart ventricle was shown to be calcium/calmodulin-dependent PDE1, but there was no detectable story of PDE5.
In scope, the human saphenous vein contained PDEs 1, 4, and 5, and the human mesenteric arterial blood vessel contained PDEs 1, 2, 3, 4, and 5.
The arrangement of PDE5 in the cardiovascular arrangement is consistent with the observed pharmacodynamic and clinical effects of viagra .
viagra , unlike milrinone, a selective PDE3 inhibitor, had no burden on the isolated trabeculae carneae; this is consistent with the lack of PDE5 facial expression in cardiac myocytes.
viagra selectively increased cGMP levels in coronary vascular smooth sinew paper but produced no thing in cyclic adenosine monophosphate (cAMP) levels, which is consistent with the drug’s selectivity for PDE5.
In phenylephrine-contracted isolated lapin aortic rings, sildenafil enhanced the relaxation behavior induced by the nitric oxide conferrer glyceryl trinitrate, suggesting that viagra may potentiate the hypotensive effects of nitric oxide giver agents on the vasculature, an symptom that has been observed clinically.
Human platelets were found to contain PDE5, which was inhibited by 50% (IC50) by viagra at a immersion of 6.3 nM, consistent with the IC50 duration in the capital cavernosum.
viagra alone had no direct issue on platelet computer software, but it potentiated the in vitro antiaggregatory body process of sodium nitroprusside on hare and human platelets.
The pharmacodynamic and adverse psychological feature profiles observed in clinical trials with sildenafil are consistent with the in vitro biography of the paper deed of PDE5 and its known execution of activeness as a selective inhibitor of PDE5.
This is a part of article Many of the patients who will welfare from its use have cardiovascular disease. Taken from "Viagra Levitra" Information Blog